$16.69
-0.58 (-3.36%)
Open$17.12
Previous Close$17.27
Day High$17.18
Day Low$16.50
52W High$22.51
52W Low$14.90
Volume—
Avg Volume61.2K
Market Cap215.81M
P/E Ratio—
EPS$-2.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+133.3% upside
Current
$16.69
$16.69
Target
$38.94
$38.94
$25.16
$38.94 avg
$46.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.28M | 22.37M | 84.88M |
| Net Income | -27,140,756 | -28,343,792 | 12.73M |
| Profit Margin | -140.8% | -133.8% | 15.0% |
| EBITDA | -27,920,455 | -30,777,944 | 16.15M |
| Free Cash Flow | — | — | 13.25M |
| Rev Growth | -13.8% | -13.8% | +19.4% |
| Debt/Equity | 0.20 | 0.20 | 1.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |